2025-26 Guide to Medications for the Treatment of Diabetes Mellitus
Product details
| Management number | 231836451 | Release Date | 2026/06/18 | List Price | US$16.32 | Model Number | 231836451 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
The 2025-26 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, alpha-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association's Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as: Neuropathy; Chronic Kidney Disease; Retinopathy; Hypoglycemia; Obesity; Depression. Read more
| ISBN10 | 158040846X |
|---|---|
| ISBN13 | 978-1580408462 |
| Language | English |
| Publisher | American Diabetes Association |
| Dimensions | 6 x 1.51 x 9 inches |
| Item Weight | 2.2 pounds |
| Print length | 745 pages |
| Publication date | August 12, 2025 |
Bestseller ranking
Clinical Chemistry
Customers who viewed this product also viewed
Mainstays Candles
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form